HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

THE PHILIPPINES

The Philippines pharmaceutical market is valued at USD 4.4 billion in 2020, reflecting a growth rate of 8.3%. Lupin’s subsidiary, MultiCare Pharmaceuticals Philippines Inc. (MultiCare), a premium branded generics company, generated total revenues of PHP 1,760 million, recording a growth of 13% compared with the previous year. MultiCare has a strong presence in rheumatology, gastrointestinal, and Diabetes segments. MultiCare remains the 5th largest branded generic players in the Philippines.